Edition:
United Kingdom

Enanta Pharmaceuticals Inc (ENTA.OQ)

ENTA.OQ on NASDAQ Stock Exchange Global Select Market

79.98USD
5:08pm BST
Change (% chg)

$1.14 (+1.45%)
Prev Close
$78.84
Open
$78.59
Day's High
$80.33
Day's Low
$78.59
Volume
15,296
Avg. Vol
95,971
52-wk High
$127.74
52-wk Low
$44.54

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Hold 1.15 September 19 Oct 2018

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 0 0 0 1
(2) OUTPERFORM 2 2 2 2
(3) HOLD 4 4 4 3
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 2.67 2.67 2.67 2.33

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Sep-18 6 67.99 70.80 67.00 17.30
Quarter Ending Mar-19 3 45.06 45.73 44.35 --
Year Ending Sep-18 6 207.33 210.22 206.00 67.90
Year Ending Sep-19 6 209.81 260.00 170.70 76.75
Earnings (per share)
Quarter Ending Sep-18 6 1.15 1.31 1.03 -0.18
Quarter Ending Mar-19 4 0.37 0.42 0.29 --
Year Ending Sep-18 6 3.32 3.39 3.19 -0.91
Year Ending Sep-19 6 2.10 4.13 0.81 -1.03

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Jun-18 56.93 57.26 0.33 0.58
Quarter Ending Mar-18 40.77 44.05 3.28 8.05
Quarter Ending Dec-17 31.15 38.11 6.96 22.33
Quarter Ending Sep-17 73.80 75.93 2.13 2.88
Quarter Ending Jun-17 8.07 7.51 0.56 6.98
Earnings (per share)
Quarter Ending Jun-18 0.98 0.97 0.01 1.02
Quarter Ending Mar-18 0.52 0.61 0.09 16.19
Quarter Ending Dec-17 0.19 0.78 0.59 310.53
Quarter Ending Sep-17 2.13 1.86 0.27 12.78
Quarter Ending Jun-17 -0.48 -0.44 0.04 -8.33

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Sep-18 67.99 67.99 68.01 68.01 17.30
Quarter Ending Mar-19 45.06 45.06 45.06 45.06 --
Year Ending Sep-18 207.33 207.33 207.36 207.36 67.90
Year Ending Sep-19 209.81 209.81 208.62 208.62 76.75
Earnings (per share)
Quarter Ending Sep-18 1.15 1.15 1.15 1.15 -0.18
Quarter Ending Mar-19 0.37 0.37 0.37 0.37 --
Year Ending Sep-18 3.32 3.32 3.32 3.32 -0.91
Year Ending Sep-19 2.10 2.10 2.06 2.06 -1.03

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Sep-18 0 0 0 1
Quarter Ending Mar-19 0 0 0 0
Year Ending Sep-18 0 0 0 1
Year Ending Sep-19 0 0 1 0
Earnings
Quarter Ending Sep-18 0 0 0 0
Quarter Ending Mar-19 0 0 0 0
Year Ending Sep-18 0 0 0 0
Year Ending Sep-19 0 0 1 0